These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2575523)

  • 1. The alpha 2-adrenoceptor antagonists idazoxan and yohimbine can unmask the postsynaptic dopamine agonist effects of B-HT 920.
    Meltzer LT; Wiley JN; Heffner TG
    Eur J Pharmacol; 1989 Oct; 170(1-2):105-7. PubMed ID: 2575523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence.
    Johansen PA; Clarkl D; White FJ
    Life Sci; 1988; 43(6):515-24. PubMed ID: 2900459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of idazoxan on the dopamine D2 receptor agonist-induced behavioural effects in rats.
    Ferrari F; Giuliani D
    Eur J Pharmacol; 1993 Nov; 250(1):51-7. PubMed ID: 7907024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha 2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats.
    Sanger DJ
    Psychopharmacology (Berl); 1988; 95(3):413-7. PubMed ID: 2901129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of dopamine receptor-mediated responses by B-HT 920 in mice.
    Chopra K; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1988; 294():46-55. PubMed ID: 2906798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the alpha 2-adrenoceptor antagonists yohimbine and idazoxan on kidney function in intact and diabetes insipidus rats.
    Farjam A; Greven J
    Urol Int; 1989; 44(5):255-9. PubMed ID: 2572085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.
    Sanger DJ
    Psychopharmacology (Berl); 1988; 96(2):243-9. PubMed ID: 2906748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of yohimbine and idazoxan on monoamine metabolites in rat cerebrospinal fluid.
    Scheinin H; Virtanen R
    Life Sci; 1986 Oct; 39(16):1439-46. PubMed ID: 2430157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat.
    Eriksson E; Svensson K; Clark D
    Life Sci; 1985 May; 36(19):1819-27. PubMed ID: 3990512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological demonstration of both alpha 2-agonist and antagonist properties of RX 781094.
    Goldstein JM; Knobloch LC; Malick JB
    Eur J Pharmacol; 1983 Jul; 91(1):101-5. PubMed ID: 6137390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
    Gadie B; Lane AC; McCarthy PS; Tulloch IF; Walter DS
    Br J Pharmacol; 1984 Nov; 83(3):707-12. PubMed ID: 6150739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that serotonin receptors are involved in the anticonvulsant effect of yohimbine in mice.
    Ludvig N; György L; Vizi ES
    Psychopharmacology (Berl); 1986; 88(1):82-5. PubMed ID: 2868485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of yohimbine and idazoxan on the systemic and regional hemodynamics of waking rats].
    Ivashev MN; Medvedev OS; Giulumian AD
    Farmakol Toksikol; 1991; 54(5):20-2. PubMed ID: 1686868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
    Pifl C; Pichler L; Kobinger W; Hornykiewicz O
    Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist.
    Rabloczky G; Jaszlits L; Horváth E
    Acta Physiol Hung; 1991; 77(3-4):257-67. PubMed ID: 1684485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of locally applied noradrenergic agents at cerebellar Purkinje neurons: receptor specificity.
    Parfitt KD; Freedman R; Bickford-Wimer PC
    Brain Res; 1988 Oct; 462(2):242-51. PubMed ID: 2847850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existence of spare alpha 1-adrenoreceptors, but not alpha 2-adrenoreceptors, for respective vasopressor effects of cirazoline and B-HT 933 in the pithed rat.
    Ruffolo RR; Yaden EL
    J Cardiovasc Pharmacol; 1984; 6(6):1011-9. PubMed ID: 6084756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
    Brown MJ; Harland D
    Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of yohimbine and idazoxan on motor behaviors in male rats.
    Bowes MP; Peters RH; Kernan WJ; Hopper DL
    Pharmacol Biochem Behav; 1992 Apr; 41(4):707-13. PubMed ID: 1350682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.